Skip to content

Robert W. Rebar

NPI 1699888164ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Birmingham, AL

Obstetrics & Gynecology, Reproductive Endocrinology in Birmingham, Alabama, licensed in AL, with an NPI issued in August 2006. Sumitomo Pharma America, Inc. was the largest of 2 companies reporting payments in 2025, $3,675 in all, mostly consulting fees.

Overview

NPI1699888164
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedAug 17, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$3,675 · 3 payments from 2 companies
  • 2024$4,629 · 2 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Sumitomo Pharma America, Inc.$2,9252
Merck Sharp & Dohme LLC$750.001

What the 2025 payments were for

  • Consulting Fee$3,675 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Birmingham

All 19 Obstetrics & Gynecology, Reproductive Endocrinology providers in Birmingham · All Obstetrics & Gynecology, Reproductive Endocrinology providers in Alabama